10x Genomics
10x Genomics is a life science technology company based in Pleasanton, California, that specializes in developing instruments, consumables, and software for the analysis of biological systems. Founded in 2012, the company offers a range of products, including Chromium instruments, microfluidic chips, slides, reagents, and various consumable products. Its innovative single cell solutions enable researchers to assess gene expression, immune profiling, epigenetics, and cellular heterogeneity at an individual cell level. The Visium spatial gene expression solution allows for the analysis of gene expression patterns across tissue samples, providing valuable insights into biological processes. 10x Genomics serves a diverse client base, including academic institutions, government organizations, and biopharmaceutical companies across multiple regions, including North America, Europe, and Asia. The company generates the majority of its revenue from consumables, underscoring its focus on providing essential tools for genomic research.
Tetramer Shop
Acquisition in 2021
Tetramer Shop is a biotechnology company focused on developing drug technology centered around MHC tetramers. Its primary objective is to enhance the testing and monitoring of antigen-specific T cells, which are crucial for understanding immune responses. The company caters to a diverse clientele, including academic research institutions and therapeutic development laboratories, with applications extending to cancer vaccine development. Through its innovative approach, Tetramer Shop aims to support advancements in immunology and personalized medicine.
ReadCoor
Acquisition in 2020
ReadCoor, Inc. is a technology company based in Cambridge, Massachusetts, specializing in the development and commercialization of a panomic spatial sequencing platform designed for researchers, clinicians, and pharmaceutical and diagnostics companies. The company's innovative platform, based on proprietary Fluorescent in situ Sequencing (FISSEQ) technology, enables the simultaneous detection and analysis of RNA, DNA, proteins, and therapeutics, while providing high-resolution three-dimensional imaging of tissue samples. This integration allows for comprehensive morphometric analysis and cellular localization, facilitating a deeper understanding of human biology and the advancement of therapeutic development. ReadCoor aims to support clients in accessing valuable clinical insights for treating various diseases, including cancer, infectious diseases, and neurological disorders. Established in 2016, ReadCoor operates as a subsidiary of 10x Genomics, Inc.
Cartana
Acquisition in 2020
Cartana AB is a biotechnology company based in Solna, Sweden, specializing in mapping gene expression in brain tissue through In Situ Sequencing (ISS). Founded in 2017, Cartana's innovative technology allows for the simultaneous analysis of hundreds of genes within individual cells while preserving tissue morphology. This capability is essential for advancing research and biomarker discovery, treatment validation, and the development of future diagnostic tools. The company's flagship product, NeuroKit: Brain Cell Mapping, can identify over 100 genes in a single tissue section. Cartana also provides sequencing services that include sample preparation and analysis, facilitating deeper understanding of brain functions and diseases as well as tumors and other organs. As of August 2020, Cartana operates as a subsidiary of 10x Genomics, Inc.
Cartana
Acquisition in 2020
Cartana AB is a biotechnology company based in Solna, Sweden, specializing in mapping gene expression in brain tissue through In Situ Sequencing (ISS). Founded in 2017, Cartana's innovative technology allows for the simultaneous analysis of hundreds of genes within individual cells while preserving tissue morphology. This capability is essential for advancing research and biomarker discovery, treatment validation, and the development of future diagnostic tools. The company's flagship product, NeuroKit: Brain Cell Mapping, can identify over 100 genes in a single tissue section. Cartana also provides sequencing services that include sample preparation and analysis, facilitating deeper understanding of brain functions and diseases as well as tumors and other organs. As of August 2020, Cartana operates as a subsidiary of 10x Genomics, Inc.
Spatial Transcriptomics
Acquisition in 2018
Spatial Transcriptomics AB is a life sciences company based in Stockholm, Sweden, that specializes in technology for analyzing tissue samples and gene expression data in two dimensions. The company's innovative solutions enable users to visualize and quantify gene expression within the histological context, facilitating comparisons of gene expression patterns based on tissue morphology and cellular characteristics. Their offerings include tissue optimization, library preparation, sequencing, and data visualization tools, as well as a specialized data format for gene expression analysis. Founded in 2012, Spatial Transcriptomics AB has established a strategic partnership with Seven Bridges and operates as a subsidiary of 10X Genomics, Inc. The technology developed by the company is applicable to various fields, including human and mouse research, providing valuable insights into cellular functions and interactions.
EPINOMICS
Acquisition in 2018
Epinomics Inc. specializes in advancing personalized medicine by leveraging big data analytics and proprietary epigenomics technology. Founded in 2013 and located in Menlo Park, California, the company focuses on decoding the human genome to enhance drug development and clinical applications. By utilizing innovative DNA sequencing technology, Epinomics aims to improve existing methodologies in the field, facilitating deeper scientific research and the development of clinical applications. As of March 31, 2018, Epinomics operates as a subsidiary of 10X Genomics, Inc., furthering its mission to revolutionize healthcare through precision medicine.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.